Rare diseases
Investigational molecules
Locations
1 Main Street, 02142-1531, United States
Epizyme Inc. is active in clinical research for relapsed/refractory follicular lymphoma, with studies centered on treatment approaches for patients whose disease has returned or no longer responds to prior therapy. The sponsor’s research includes combinations with lenalidomide and rituximab in adult patients.
Clinical interest also extends to ongoing evaluation of long-term safety in patients remaining on tazemetostat-based treatment.
Epizyme Inc. runs clinical trials in conditions such as Follicular lymphoma, Non-Hodgkin's lymphoma, Limb reduction defect, Neurofibrosarcoma, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Belgium
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
